← All organizations
Highest phase reached
Phase 1
First clinical trial
Jun 11, 2018Last known activity
Jun 16, 2023
Timeline
2010s
- Jun 1, 2012
CRO ClinPharmInvest— Founded
Drugs by trial phase (12 distinct, 13 trials)
Phase 1 (12 own, 0 via acquisition)
Recent trials (25)
- NCT05934799CollaboratorPhase 1Jun 16, 2023
- NCT05642845CollaboratorPhase 1Nov 11, 2022
- NCT05642845Overall official - principal investigatorPhase 1Nov 11, 2022
- NCT05061901Overall official - principal investigatorPhase 1Oct 6, 2021
- NCT05061901CollaboratorPhase 1Oct 6, 2021
- NCT04921566CollaboratorPhase 1Jun 5, 2021
- NCT04921566Overall official - principal investigatorPhase 1Jun 5, 2021
- NCT04882826CollaboratorPhase 1May 10, 2021
- NCT04882826Overall official - principal investigatorPhase 1May 10, 2021
- NCT04830579CollaboratorPhase 1Apr 10, 2021
- NCT04830579Overall official - principal investigatorPhase 1Apr 10, 2021
- NCT04753489CollaboratorPhase 1Feb 13, 2021
- NCT04753489Overall official - principal investigatorPhase 1Feb 13, 2021
- NCT04729998CollaboratorPhase 1Jan 30, 2021
- NCT04729998Overall official - principal investigatorPhase 1Jan 30, 2021
Details
- Founded
- Yaroslavl, RU Jun 1, 2012
- Last known activity
- Jun 16, 2023
Notes
CRO